first month glp-1 treatment expectations The Revolution Continues GLP-1 Medications: Weight Loss &

Key findings Patients mean age at initiation was 55.1 (13.3) years, 65.2% were female, 73.7% were white, and 61.3% had T2D

She argues that health insurers will still incur costs in the long run if people cant use GLP-1 medications to prevent more serious health conditions that can develop from obesity

Company builds on nearly 10 years of GLP-1 experience, expanding its Sustainable Weight Loss solution to deliver medication-free and medication-assisted weight loss DENVER--(BUSINESS WIRE)-- Virta Health has released first-of-its-kind, peer-reviewed data demonstrating the companys approach to personalized nutrition therapy results in sustained weight loss after the discontinuation of glucagon-like peptide-1 receptor agonists (GLP-1s), including Ozempic

Be sure to let your clinician know about all medications youre taking